Allergy最新文献

{"title":"Emerging Risk: Intranasal Tin Exacerbates Allergic Rhinitis in Humans and Mice","authors":"Delgama A. S. M. Nishadhi, Shogo Sumiya, Akira Tazaki, Takumi Kagawa, Mohamed Abdelmoneim, Masafumi Sakashita, Kazuhiro Ogi, Shigeharu Fujieda, Shinichi Iwasaki, Masashi Kato","doi":"10.1111/all.70180","DOIUrl":"https://doi.org/10.1111/all.70180","url":null,"abstract":"","PeriodicalId":122,"journal":{"name":"Allergy","volume":"25 1","pages":""},"PeriodicalIF":12.4,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145651137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part I-Guidelines on Intranasal Treatments.","authors":"Bernardo Sousa-Pinto,Jean Bousquet,Rafael José Vieira,Holger J Schünemann,Torsten Zuberbier,Antonio Bognanni,Alkis Togias,Boleslaw Samolinski,Arunas Valiulis,Sian Williams,Anna Bedbrook,Wienczyslawa Czarlewski,Maria Jose Torres,Mohamed H Shamji,Mário Morais-Almeida,G Walter Canonica,Leticia de Las Vecillas,Mark S Dykewicz,Cristina Jacomelli,Ludger Klimek,Lucas Leemann,Olga Lourenço,Yuliia Palamarchuk,Nikolaos G Papadopoulos,Ana Margarida Pereira,Marine Savouré,Sanna K Toppila-Salmi,Maria Teresa Ventura,Juan José Yepes-Nuñez,Alvaro A Cruz,Giorgio Ciprandi,Bilun Gemicioglu,Mattia Giovannini,Brigita Gradauskiene,Tuomas Jartti,Miloš Jeseňák,Piotr Kuna,Violeta Kvedariene,Désirée E Larenas-Linnemann,Amir Ha Latiff,Yousser Mohammad,Ken Ohta,Padukudru A Mahesh,Isabella Pali-Schöll,Oliver Pfaar,Frederico S Regateiro,Nicolas Roche,Luís Taborda-Barata,Charlotte Suppli Ulrik,Marylin Valentin Rostan,Giovanni Viegi,Luo Zhang,Tari Haahtela,Ivan Cherrez-Ojeda,Juan Carlos Ivancevich,Nikolai Khaltaev,Arzu Yorgancioglu,Baharudin Abdullah,Mona Al-Ahmad,Maryam Ali Al-Nesf,Rita Amaral,Julijana Asllani,Karl-C Bergmann,Jonathan A Bernstein,Michael S Blaiss,Fulvio Braido,Paulo Camargos,Pedro Carreiro-Martins,Thomas Casale,Lorenzo Cecchi,Alessandro Fiocchi,Antonio F M Giuliano,George Christoff,Ieva Cirule,Jaime Correia de Sousa,Elisio M Costa,Stefano Del Giacco,Philippe Devillier,Dejan Dokic,Elham Hossny,Tomohisa Iinuma,Carla Irani,Zhanat Ispayeva,Kaja Julge,Igor Kaidashev,Kazi S Bennoor,Helga Kraxner,Inger Kull,Marek Kulus,Maciej Kupczyk,Andriy Kurchenko,Stefania La Grutta,Neven Miculinic,Lan Le Thi Tuyet,Michael Makris,Branislava Milenkovic,Sang Min Lee,Stephen Montefort,Andre Moreira,Joaquim Mullol,Rachel Nadif,Alla Nakonechna,Hugo E Neffen,Marek Niedoszytko,Dieudonné Nyembue,Robyn E O'Hehir,Ismail Ogulur,Yoshitaka Okamoto,Heidi Olze,Oscar Palomares,Petr Panzner,Vincenzo Patella,Ruby Pawankar,Constantinos Pitsios,Todor A Popov,Francesca Puggioni,Santiago Quirce,Agné Ramonaité,Marysia Recto,Maria Susana Repka-Ramirez,Graham Roberts,Karla Robles-Velasco,Menachem Rottem,Marianella Salapatas,Joaquin Sastre,Nicola Scichilone,Juan-Carlos Sisul,Dirceu Solé,Manuel E Soto-Martinez,Milan Sova,Pongsakorn Tantilipikorn,Ana Todo-Bom,Vladyslav Tsaryk,Ioanna Tsiligianni,Marilyn Urrutia-Pereira,Erkka Valovirta,Tuula Vasankari,Dana Wallace,De Yun Wang,Margitta Worm,Osman M Yusuf,Mihaela Zidarn,Sara Gil-Mata,Manuel Marques-Cruz,Bassam Mahboub,Ignacio J Ansotegui,Antonino Romano,Werner Aberer,Maria Cristina Artesani,Elena Azzolini,Bruno Barreto,Joan Bartra,Sven Becker,Bianca Beghe,Attilio Boner,Ewa Borowiack,Jacques Bouchard,Melisande Bourgoin-Heck,Luisa Brussino,Roland Buhl,José Antonio Castillo-Vizuete,Denis Charpin,Niels H Chavannes,Marta Chełmińska,Lei Cheng,Ekaterine Chkhartishvili,Seong H Cho,Herberto Jose Chong-Neto,Deepa Choudhury,Derek K Chu,Cemal Cingi,Enrico Compalati,Raquel Albuquerque Costa,Olga Mariana Cunha,Biljana Cvetkovski,Victoria Cardona-Dahl,Gennaro D'Amato,Janet Davies,Danilo Di Bona,Sandra N Gonzalez Diaz,Maria V Dimou,Maria Doulaptsi,Renato Ferreira-da-Silva,Radoslaw Gawlik,Mario Calvo-Gil,Ozlem Goksel,Maximiliano R Gómez,Maia Gotua,Christos Grigoreas,Ineta Grisle,Maria Antonieta Guzman,Rachel House Tan,Michael Hyland,Despo Ierodiakonou,Aspasia Karavelia,Paul Keith,Marta Kisiel,Tanja Soklic Kosak,Mitja Kosnik,Ilgim Vardaloglu Koyuncu,Vicky Kritikos,Justyna Litynska,Carlo Lombardi,Gilles Louis,Matteo Martini,Cem Meço,Eris Mesonjesi,Florin Mihaltan,Marcin Moniuszko,Robert N Naclerio,Kari C Nadeau,Sophia Neisinger,Markus Ollert,Michal Ordak,Giovanni Paoletti,Hae-Sim Park,Elena Parmelli,Edgar Arturo Perdomo-Flores,José Miguel Fuentes Pérez,Nhan Pham-Thi,Emmanuel Prokopakis,Inês Ribeiro-Vaz,Giovanni Rolla,Jan Romantowski,Philippe Rombaux,Philip W Rouadi,Maia Rukhadze,Dermot Ryan,Ewelina Sadowska,Daiju Sakurai,Laila Salameh,Faradiba Serpa Sarquis,Elie Serrano,Jane Da Silva,Michael Soyka,Krzysztof Specjalski,Vesna Tomic-Spiric,Katarina Stevanovic,Abirami Subramaniam,Maria Do Ceu Teixeira,Tuuli Thomander,Martina Vachova,Marianne van Hage,Pakit Vichyanond,Martin Wagenmann,Fanny Wai San Ko,Pascal Werminghaus,Paraskevi Vicky Xepapadaki,Yi-Kui Xiang,Qintai Yang,Daniela Rivero Yeverino,Jaron Zuberbier,João A Fonseca","doi":"10.1111/all.70131","DOIUrl":"https://doi.org/10.1111/all.70131","url":null,"abstract":"BACKGROUNDAllergic rhinitis (AR) impacts quality of life, work and school productivity. Over the last years, an important body of evidence resulting from mHealth data has led to a better understanding of AR. Such advances have motivated an EAACI-endorsed update of the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines (ARIA 2024-2025). This manuscript presents the ARIA 2024-2025 recommendations for intranasal treatments, one of the mainstays for AR management.METHODSThe ARIA 2024-2025 guideline panel issued recommendations following the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) evidence-to-decision framework. Several sources of evidence were used to inform panel judgments and recommendations, including systematic reviews, evaluation of mHealth and pharmacovigilance data, as well as a survey of experts on costs.RESULTSEleven guideline questions concerning intranasal treatments for AR were prioritized, leading to recommendations. Overall, these questions concern the choice between different classes of intranasal medications-most notably, intranasal corticosteroids (INCS), antihistamines (INAH), fixed combinations of INAH+INCS and decongestants-or between different individual medications within each class. Four questions had not been evaluated in previous ARIA guidelines, while for the other three there was a change in the strength or directionality of recommendations. Overall, recommendations point to the suggested use of INAH+INCS over INAH or INCS and INCS over INAH.CONCLUSIONThis ARIA 2024-2025 article supports patients, their caregivers, and healthcare professionals in choosing an intranasal treatment. However, decisions on AR treatment should consider the clinical variability of the disease, patients' values, and the affordability of medications.","PeriodicalId":122,"journal":{"name":"Allergy","volume":"25 1","pages":""},"PeriodicalIF":12.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145644890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Heat-Not-Burn Tobacco Aerosols Induce Immune Dysregulation and Barrier Disruption Comparable to Conventional Cigarettes.","authors":"Dilara Karaguzel,Alicja Walewska,Basak Ezgi Sarac,Marlena Tynecka,Kinga Bondarczuk,Agnieszka Tarasik,Dariusz Kisiel,Karolina Partyk,Damian Pogodziński,Bartosz Hanczaruk,Alicja Toczydlowska,Cagla Bicakci,Doga Oztabak,Magdalena Niemira,Adam Kretowski,Marlena Dubatowka,Natalia Ogrodnik,Malgorzata Chlabicz,Pawel Sowa,Karol Kaminski,Marcin Moniuszko,Andrzej Eljaszewicz,Cagatay Karaaslan","doi":"10.1111/all.70174","DOIUrl":"https://doi.org/10.1111/all.70174","url":null,"abstract":"BACKGROUNDHeat-not-burn (HnB) tobacco products are marketed as a safer alternative to conventional cigarettes (CC), yet their health effects remain controversial, largely based on industry-funded studies. We aimed to assess lung function in HnB and CC users and examine the mechanistic effects of HnB exposure using animal and in vitro models.METHODSSpirometry data from 650 non-smokers (NS), 293 CC smokers, and 49 HnB users enrolled in the Bialystok-PLUS cohort were analyzed. To investigate underlying mechanisms, a whole-body mouse exposure model was performed with HnB aerosol or 3R4F cigarette smoke, assessing lung transcriptomic profiles (by means of RNA sequencing), lung inflammation (by flow cytometry and histochemical staining), and barrier integrity (by using immunofluorescent staining). Moreover, an in vitro ALI-culture model of human airway epithelial cells was used to validate the mouse experiments. The effect of HnB and CC was assessed through cytotoxic effect (MTT and LDH), inflammatory responses (cytokine release by ELISA), and tight junction proteins (immunofluorescence staining).RESULTSpirometric analysis (FEV1, FVC, VC) revealed no significant overall differences in lung function among HnB users, CC smokers, and non-smokers (NS) in the unadjusted comparison. However, subgroup analyses showed that younger (< 45 years) HnB users and those with shorter smoking histories (< 20 years) already exhibited significantly lower FEV1, FVC, and VC compared to NS and CC smokers. After adjustment for age and smoking-related covariates, HnB users displayed modest but significant reductions in static FEV1 and FVC relative to NS, while no adjusted differences were detected between HnB and CC groups, indicating comparable baseline ventilatory function. Both exposures in mice increased eosinophils and B cell counts by ~2-fold, while decreasing ST2+ CD4+ T cells over 80%, and induced epithelial apoptosis. HnB aerosol selectively reduced basophils by almost 50%. Both HnB and CC exposure in mice caused significant epithelial damage and impaired airway barrier function, evidenced by a ~60% reduction in ZO-1. Transcriptomic analysis revealed that CC smoke triggered a robust inflammatory gene response, whereas HnB aerosol predominantly altered metabolic pathways. In vitro, barrier function was impaired under both conditions, but cytokine secretion increased only after CC smoke exposure.CONCLUSIONDespite different molecular impacts, HnB aerosol exposure induces a level of airway epithelial injury and immune cell infiltration comparable to CC smoke. Our findings challenged the narrative of HnB products being a harmless alternative and highlight their potential to cause significant lung pathology.","PeriodicalId":122,"journal":{"name":"Allergy","volume":"151 1","pages":""},"PeriodicalIF":12.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145644897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"New Allergens Approved by the WHO/IUIS Allergen Nomenclature Sub-Committee in 2021-2024 and Their Significance for Future Diagnostics, Regulation, and Research. An EAACI Task Force Report.","authors":"Christian Radauer,Gabriele Gadermaier,Richard E Goodman,Alain Jacquet,Uta Jappe,Andreas L Lopata,Anna Pomés,Monika Raulf,Keity S Santos,Josefina Zakzuk,Yuzhu Zhang,Joana Vitte, ","doi":"10.1111/all.70166","DOIUrl":"https://doi.org/10.1111/all.70166","url":null,"abstract":"The WHO/IUIS Allergen Nomenclature Sub-Committee is an international body of experts that maintains the systematic nomenclature of allergenic proteins by assigning official names to newly identified allergens submitted by researchers. Here, we summarize the data on new allergens approved between 2021 and 2024. The sub-committee assigned names to 112 new allergens with 124 isoallergens/variants as well as 26 new isoallergens/variants of previously named allergens. Most new allergens were respiratory allergens from animals (35 allergens) and plants (25) as well as food allergens from animals (22) and plants (17). Many newly identified allergens reflect globalized allergen exposure and growing research activities outside of Western countries. This is illustrated by allergens from the tropical mite Blomia tropicalis, pollen allergens from tree and weed species native to Asia, and food allergens from regionally important foods such as mango, seafood, silkworm pupae, and natto. The allergen profiles of most relevant sources are well established, but gaps in our knowledge remain, particularly regarding allergens important for populations outside of Europe and North America. The still growing number of known allergens highlights the importance of a consistent, unambiguous allergen nomenclature that evolves with clinical demands and scientific discovery and supports efforts to close existing knowledge gaps.","PeriodicalId":122,"journal":{"name":"Allergy","volume":"13 1","pages":""},"PeriodicalIF":12.4,"publicationDate":"2025-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145619808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Protein Glycosylation: An Emerging Regulator of Allergic Diseases.","authors":"Pan Li,Xianghong Wang,Ming Zeng,Zheng Liu","doi":"10.1111/all.70171","DOIUrl":"https://doi.org/10.1111/all.70171","url":null,"abstract":"Type 2 (T2) inflammation is central to allergic disorders. Glycosylation, a post-translational modification, is emerging as a pivotal regulator in T2 inflammation and associated allergic diseases. This review synthesizes current knowledge on glycosylation patterns of key T2 inflammation players, including cytokines, immunoglobulins (e.g., IgE, IgG4) and their receptors, STAT6, mucins, and CTLA-4. We detail how site-specific glycosylation fine-tunes cytokine-receptor interactions, alters signaling pathways, and stabilizes proteins, thereby dictating their bioactivity. Moreover, we examine the enzymatic machinery orchestrating these glycosylation events and the regulatory factors modulating their activity in the context of T2 inflammation. By leveraging these mechanistic insights, we highlight how glycosylation aberrations contribute to food allergy, eosinophilic esophagitis, asthma, allergic rhinitis, and atopic dermatitis, while allergen immunotherapy exploits glycosylation reprogramming (e.g., sialylated IgG4 induction) to restore immune tolerance. Furthermore, we explore the diagnostic and prognostic potential of glycosylation patterns in predicting disease severity and allergen immunotherapy responsiveness, while underscoring the therapeutic promise of targeting glycosylation enzymes or glycan-immune receptor interactions to mitigate T2 inflammation-driven pathologies. A deeper understanding of glycosylation dynamics in T2 inflammation not only enhances our grasp of disease pathogenesis but also opens new avenues for innovative therapeutic interventions.","PeriodicalId":122,"journal":{"name":"Allergy","volume":"4 1","pages":""},"PeriodicalIF":12.4,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145613350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Oral Immunotherapy Induces Shift in lncRNA Expression Modulating Allergen-Specific Immune Responses.","authors":"Olivia Liong,Kati Palosuo,Victoria Hinkkanen,Vittorio Fortino,Mika J Mäkelä,Piia Karisola","doi":"10.1111/all.70173","DOIUrl":"https://doi.org/10.1111/all.70173","url":null,"abstract":"BACKGROUNDPreviously, we reported the success of egg oral immunotherapy (OIT) in liberating most participants from dietary restrictions. The diminishing symptoms and declining inflammation were accompanied by differential expression of genes in peripheral blood mononuclear cells (PBMCs) of 50 egg-allergic children following 8 months of OIT.METHODSHere, we explore the impact of OIT on long non-coding RNA (lncRNA) expression and its downstream effects on allergen-specific immune response with the help of PBMC transcriptome, co-expression gene module identification, pathway enrichment analyses and in vitro stimulation in both PBMC and THP1 cells.RESULTSWe observed 17 lncRNAs which correlated positively with genes involved in IL-13, IL-4, and IL-10 signaling pathways. The same set of lncRNAs correlated negatively with genes playing a role in neutrophil degranulation, phagosome formation, and pyroptosis signaling. The expression of one of the most important lncRNAs, LOC644727, was found to align with CXCL8 expression in egg extract-stimulated PBMCs and LPS-stimulated THP1-derived macrophages.CONCLUSIONSOur results highlight the involvement of lncRNA in the regulation of gene expression during OIT. LOC644727 may serve as a potential marker for inflammatory responses and it may offer a therapeutic target for future desensitization protocols.","PeriodicalId":122,"journal":{"name":"Allergy","volume":"68 1","pages":""},"PeriodicalIF":12.4,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145613349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Transplacental Antimicrobial Antibodies and Childhood Asthma: Maternal Nativity as an Upstream Factor","authors":"Xiumei Hong,&nbsp;Kari C. Nadeau,&nbsp;Pamela Frischmeyer-Guerrerio,&nbsp;Guoying Wang,&nbsp;August F. Jernbom,&nbsp;Shuai Li,&nbsp;Ni Zhao,&nbsp;William R. Morgenlander,&nbsp;Julia W. Angkeow,&nbsp;Manju Thakar,&nbsp;Colleen Pearson,&nbsp;William G. Adams,&nbsp;H. Benjamin Larman,&nbsp;Hongkai Ji,&nbsp;Xiaobin Wang","doi":"10.1111/all.70167","DOIUrl":"10.1111/all.70167","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Early-life microbial exposure to microbes may play a role in asthma development. This study tests the hypothesis that mothers born in low-income countries might have been exposed to diverse microbes—leading to greater diversity and higher levels of transplacental anti-microbial antibodies, thereby conferring protection against asthma in offspring.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>In the prospective Boston Birth Cohort, IgG antibody reactome against microbes (2740 species; 1311 genera) was profiled in cord blood, using Phage ImmunoPrecipitation Sequencing. Multinomial regression models were applied to examine the associations of cord blood IgG reactome with child risk of physician-diagnosed atopy and asthma. Mediation analysis was performed to examine the inter-relationships among maternal nativity, IgG reactome and risk of developing childhood asthma.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>This report included 943 mother–child dyads enrolled at birth and followed prospectively. Compared to children of US-born mothers, children of foreign-born mothers had a lower prevalence of asthma (17.5% vs. 30.5%) and greater diversity of cord blood IgG antibodies against hundreds of microbes (FDR &lt; 0.05). Cord blood seropositivity to peptides or proteins from 6 microbes was inversely associated with the risk of asthma in children, and children with more seropositivity to these microbes were at a lower risk of developing asthma (<i>p</i> &lt; 0.001). IgG seropositivity to <i>A. actinomycetemcomitans, H. pylori</i>, <i>S. flexneri</i>, and <i>T. parva</i> each mediated 17%–62% of the association between maternal nativity and child risk of asthma.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>In this US prospective birth cohort, maternal transplacental IgG reactivity to four microbes (<i>A. actinomycetemcomitans</i>, <i>H. pylori</i>, <i>S. flexneri and T. parva</i>) was associated with a lower risk of childhood asthma, and partly explains the lower risk of asthma in children of mothers born outside the US.</p>\u0000 </section>\u0000 </div>","PeriodicalId":122,"journal":{"name":"Allergy","volume":"81 1","pages":"197-208"},"PeriodicalIF":12.0,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145609105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Correspondence to ‘Hypersensitivity Reactions to Human Albumin—A Case Series and Diagnostic Algorithm’","authors":"Juliette Charpy, Mathilde Seydoux, Antoine Giraudon, Julien Bonnac, Maxime Dubois, Maryline Bordes‐Demolis, Christelle Pellerin, Julien Goret","doi":"10.1111/all.70168","DOIUrl":"https://doi.org/10.1111/all.70168","url":null,"abstract":"","PeriodicalId":122,"journal":{"name":"Allergy","volume":"118 1","pages":""},"PeriodicalIF":12.4,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145609801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Assessment of the Severity of Atopic Dermatitis Using Atomic Force Microscopy Analysis of Skin Tape Strips","authors":"Ching‐Wen Du, Jen‐Hung Wang, Jorge Pereda, Ivone Jakasa, Maria Oberländer Christensen, Sanja Kezic, Arthur Dervillez, Jacob P. Thyssen, Edwin En‐Te Hwu, Chia‐Yu Chu","doi":"10.1111/all.70170","DOIUrl":"https://doi.org/10.1111/all.70170","url":null,"abstract":"","PeriodicalId":122,"journal":{"name":"Allergy","volume":"98 1","pages":""},"PeriodicalIF":12.4,"publicationDate":"2025-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145599728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Major Cat Allergen Fel d 4: Structure and Identification of a Cross‐Reactive IgE ‐Epitope‐Containing Area","authors":"Nikolina Todorović, Daria Trifonova, Zicheng Liu, Mirela Curin, Laszlo Schooltink, Theo Sagmeister, Christoph Grininger, Renata Kiss, Nina Gottstein, Bernd Gesslbauer, Andreas Winkler, Tea Pavkov‐Keller, Alexander Karaulov, Rudolf Valenta, Walter Keller","doi":"10.1111/all.70146","DOIUrl":"https://doi.org/10.1111/all.70146","url":null,"abstract":"Background Allergic sensitization to cats and other furry animals is a major cause of asthma and allergic rhinitis in more than 200 million people worldwide. According to the frequency of <jats:styled-content style=\"fixed-case\">IgE</jats:styled-content> recognition, allergen‐specific <jats:styled-content style=\"fixed-case\">IgE</jats:styled-content> levels, and allergenic activity, Fel d 4 is a major allergen in the cat ( <jats:italic>Felis domesticus</jats:italic> ). The lipocalin allergen Fel d 4 is highly homologous to dog (Can f 6) and major horse (Equ c 1) allergens. Accordingly, <jats:styled-content style=\"fixed-case\">IgE</jats:styled-content> cross‐reactivity to these allergens contributes to polysensitization and allergic responses upon exposure to different animals. Methods Fel d 4 was recombinantly produced in two systems, <jats:styled-content style=\"fixed-case\"> <jats:italic>E. coli</jats:italic> </jats:styled-content> and <jats:styled-content style=\"fixed-case\">Expi293F</jats:styled-content> mammalian cells. Recombinant forms were characterized by circular dichroism and mass spectrometry. The Fel d 4 <jats:styled-content style=\"fixed-case\">3D</jats:styled-content> structure was determined using X‐ray crystallography. Immunoreactivity, epitope analyses, and cross‐reactive properties were assessed by <jats:styled-content style=\"fixed-case\">ELISA</jats:styled-content> and basophil release assays using allergic patients’ sera. Results We reveal the <jats:styled-content style=\"fixed-case\">rFel</jats:styled-content> d 4 crystal structures and demonstrate that mammalian cells produce an N‐glycosylated recombinant Fel d 4 allergen. The C‐terminal regions of Fel d 4, Can f 6, and Equ c 1 constitute conformational <jats:styled-content style=\"fixed-case\">IgE</jats:styled-content> ‐epitope‐containing areas responsible for cross‐reactivity. Conclusion Uncovering the <jats:styled-content style=\"fixed-case\">IgE</jats:styled-content> ‐binding sites of Fel d 4 and cross‐reactive allergens contributes to future rational design of active and passive allergen‐specific treatment forms.","PeriodicalId":122,"journal":{"name":"Allergy","volume":"264 1","pages":""},"PeriodicalIF":12.4,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145593400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}